Artisan Partners Limited Partnership Buys 12,660 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Artisan Partners Limited Partnership lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 156,551 shares of the medical equipment provider's stock after purchasing an additional 12,660 shares during the period. Artisan Partners Limited Partnership's holdings in Intuitive Surgical were worth $81,713,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $82,517,000. Sycomore Asset Management grew its position in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after acquiring an additional 4,079 shares during the period. Exome Asset Management LLC raised its holdings in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after acquiring an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. boosted its stake in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock valued at $5,138,000 after buying an additional 525 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 over the last 90 days. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 0.2 %

ISRG traded up $1.09 on Tuesday, reaching $496.36. The company's stock had a trading volume of 1,609,268 shares, compared to its average volume of 1,531,881. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock has a 50 day moving average of $552.17 and a two-hundred day moving average of $533.02. The company has a market capitalization of $176.79 billion, a price-to-earnings ratio of 77.44, a P/E/G ratio of 5.85 and a beta of 1.43.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. UBS Group increased their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a report on Monday, January 27th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Evercore ISI lifted their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, CICC Research initiated coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a "neutral" rating and a $550.00 price objective for the company. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.